SH3GL3 and plasma cell myeloma: In CD138-negative multiple myeloma clonogenic cells, high SH3GL3 expression activates PI3K and FAK kinases to enhance migration and invasion, promote stemness, and increase the expression of multidrug resistance markers leading to chemoresistance [213].